Screener
Amphastar Pharmaceuticals AMPH Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $30.35M-2.2% | $6.42M-74.6% | $24.43M-35.7% | $17.35M-57.1% | $31.03M-18.2% | ||
| $8.04M-3.7% | $8.08M+9.6% | $8.07M+11.2% | $7.86M+8.8% | $8.35M+20.0% | ||
| $7.09M+11.1% | $9.27M+10.5% | $6.21M+10.2% | $6.3M+12.5% | $6.38M+10.4% | ||
| $51.32M+44.2% | $47.84M+36.4% | $32.86M+13.2% | $52.58M-12.3% | $35.59M-48.5% | ||
| $8.59M-18.7% | $9.51M-11.1% | $8.27M-33.3% | $5.35M-61.2% | $10.57M+74.8% | ||
| $44.87M+7,279% | -$16.73M-260% | -$60.57M-69.8% | -$19.62M+43.3% | -$625K+99.1% | ||
| $45.21M+15.3% | $29.49M+168% | $20.52M-51.2% | $4.85M-86.1% | $39.22M— | ||
| —— | —— | —— | $172K-98.2% | $4.13M— | ||
| $47K+27.0% | $29K-23.7% | $104K-9.6% | $44K+7.3% | $37K-99.5% | ||
| -$43.54M-44.1% | -$30.21M-108% | -$18.37M+45.7% | -$4.35M+80.9% | -$30.2M-182% | ||
| $52.68M+973% | $762K-97.6% | —— | $28.58M+1,044% | $4.91M— | ||
| $42.73M+70.7% | $38.33M+57.2% | $24.59M+48.0% | $47.24M+2.3% | $25.03M-60.3% |
FAQ
- How much cash does Amphastar Pharmaceuticals generate?
- Amphastar Pharmaceuticals (AMPH) generated $184.6M in operating cash flow over the trailing twelve months.
- What is Amphastar Pharmaceuticals's free cash flow?
- After $31.7M of capital expenditures, Amphastar Pharmaceuticals's free cash flow was $152.9M over the trailing twelve months, up 36.3% year over year.
- Where does Amphastar Pharmaceuticals's cash flow data come from?
- Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
